Patents by Inventor Hsiao Lieu

Hsiao Lieu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYSTEMS AND METHODS FOR THERAPY OF KIDNEY DISEASE AND/OR HEART FAILURE USING CHIMERIC NATRIURETIC PEPTIDES
    Publication number: 20160324930
    Abstract: Medical systems and methods for treating kidney disease alone, heart failure alone, kidney disease with concomitant heart failure, or cardiorenal syndrome are described. The systems and methods are based on delivery of a chimeric natriuretic peptide to a patient. Methods for increasing peptide levels include direct peptide delivery via either an external or implantable programmable pump.
    Type: Application
    Filed: March 14, 2016
    Publication date: November 10, 2016
    Inventors: William P. Van Antwerp, VenKatesh R. Manda, Andrew J. L. Walsh, John Burns, Daron Evans, Hsiao Lieu
  • Methods of Treatment of Heart Failure With Natriuretic Peptides
    Publication number: 20160317622
    Abstract: Methods of treating heart failure, or decreasing blood pressure, comprising administering an NP at an appropriate does, or in an amount sufficient to provide particular concentrations of NP, are provided.
    Type: Application
    Filed: March 10, 2016
    Publication date: November 3, 2016
    Inventors: Daron Evans, Hsiao Lieu, William P. Van Antwerp
  • Methods of treatment of heart failure with natriuretic peptides
    Patent number: 9314507
    Abstract: Methods of treating heart failure, or decreasing blood pressure, comprising administering an NP at an appropriate dose, or in an amount sufficient to provide particular concentrations of NP, are provided.
    Type: Grant
    Filed: October 28, 2011
    Date of Patent: April 19, 2016
    Assignee: Capricor Therapeutics, INC.
    Inventors: Daron Evans, Hsiao Lieu, William P. Van Antwerp
  • SYSTEMS AND METHODS FOR THERAPY OF KIDNEY DISEASE AND/OR HEART FAILURE USING CHIMERIC NATRIURETIC PEPTIDES
    Publication number: 20120220528
    Abstract: Medical systems and methods for treating kidney disease alone, heart failure alone, kidney disease with concomitant heart failure, or cardiorenal syndrome are described. The systems and methods are based on delivery of a chimeric natriuretic peptide to a patient. Methods for increasing peptide levels include direct peptide delivery via either an external or implantable programmable pump.
    Type: Application
    Filed: February 7, 2012
    Publication date: August 30, 2012
    Applicant: MEDTRONIC, INC.
    Inventors: William P. Van Antwerp, VenKatesh R. Manda, Andrew J. L. Walsh, John Burnes, Daron Evans, Hsiao Lieu
  • METHODS OF TREATMENT WITH NATRIURETIC PEPTIDES
    Publication number: 20120178689
    Abstract: Methods of treating heart failure, or decreasing blood pressure, comprising administering an NP at an appropriate dose, or in an amount sufficient to provide particular concentrations of NP, are provided.
    Type: Application
    Filed: October 28, 2011
    Publication date: July 12, 2012
    Inventors: Daron EVANS, Hsiao Lieu
  • Methods and Compositions for Increasing Patient Tolerability During Myocardial Imaging Methods
    Publication number: 20090081120
    Abstract: The present application discloses methods and compositions for increasing patient tolerability during myocardial imaging comprising the administration of doses of caffeine and one or more adenosine A2A receptor agonists to a mammal undergoing myocardial imaging.
    Type: Application
    Filed: June 27, 2008
    Publication date: March 26, 2009
    Inventors: Hsiao Lieu, Brent Blackburn, Luiz Belardinelli
  • Methods and Compositions for Increasing Patent Tolerability During Myocardial Imaging Methods
    Publication number: 20080213165
    Abstract: The present application discloses methods and compositions for increasing patient tolerability during myocardial imaging comprising the administration of doses of caffeine and one or more adenosine A2A receptor agonists to a mammal undergoing myocardial imaging.
    Type: Application
    Filed: August 31, 2007
    Publication date: September 4, 2008
    Inventors: Hsiao Lieu, Brent Blackburn, Luiz Belardinelli
  • Use of A2A adenosine receptor agonists
    Publication number: 20060084625
    Abstract: Myocardial imaging methods that are accomplished by administering doses of a pharmaceutical composition including regadenoson—an adenosine A2A receptor agonist—to a human undergoing myocardial imaging in an amount sufficient to achieve at least a minimal increase in average coronary peak flow velocity.
    Type: Application
    Filed: October 19, 2005
    Publication date: April 20, 2006
    Inventors: Toufigh Gordi, Ann Olmsted, Hsiao Lieu, Luiz Belardinelli